Literature DB >> 7728743

Inhibition of apoptosis during development of colorectal cancer.

A Bedi1, P J Pasricha, A J Akhtar, J P Barber, G C Bedi, F M Giardiello, B A Zehnbauer, S R Hamilton, R J Jones.   

Abstract

Colorectal tumorigenesis proceeds through an accumulation of specific genetic alterations. Studies of the mechanism by which these genetic changes effect malignant transformation have focused on the deregulation of cell proliferation. However, colorectal epithelial homeostasis is dependent not only on the rate of cell production but also on apoptosis, a genetically programmed process of autonomous cell death. We investigated whether colorectal tumorigenesis involved an altered susceptibility to apoptosis by examining colorectal epithelium from normal mucosa, adenomas from familial adenomatous polyposis, sporadic adenomas, and carcinomas. The transformation of colorectal epithelium to carcinomas was associated with a progressive inhibition of apoptosis. The inhibition of apoptosis in colorectal cancers may contribute to tumor growth, promote neoplastic progression, and confer resistance to cytotoxic anticancer agents.

Entities:  

Mesh:

Year:  1995        PMID: 7728743

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  112 in total

1.  Mink cell focus-forming murine leukemia virus infection induces apoptosis of thymic lymphocytes.

Authors:  F K Yoshimura; T Wang; F Yu; H R Kim; J R Turner
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Thymineless death in colon carcinoma cells is mediated via fas signaling.

Authors:  J A Houghton; F G Harwood; D M Tillman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration.

Authors:  Owen J Sansom; Karen R Reed; Anthony J Hayes; Heather Ireland; Hannah Brinkmann; Ian P Newton; Eduard Batlle; Patricia Simon-Assmann; Hans Clevers; Inke S Nathke; Alan R Clarke; Douglas J Winton
Journal:  Genes Dev       Date:  2004-06-15       Impact factor: 11.361

4.  Dietary fish oil promotes colonic apoptosis and mitochondrial proton leak in oxidatively stressed mice.

Authors:  Yang-Yi Fan; Qitao Ran; Shinya Toyokuni; Yasumasa Okazaki; Evelyn S Callaway; Joanne R Lupton; Robert S Chapkin
Journal:  Cancer Prev Res (Phila)       Date:  2011-04-13

5.  Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran.

Authors:  Mohammad Reza Abbaszadegan; Alireza Tavasoli; Arash Velayati; Hamid Reza Sima; Hassan Vosooghinia; Mehdi Farzadnia; Hamid Asadzedeh; Mehran Gholamin; Ezzat Dadkhah; Azadeh Aarabi
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

6.  Apoptosis and its relationship with cell proliferation, p53, Waf1p21, bcl-2 and c-myc in esophageal carcinogenesis studied with a high-risk population in northern China.

Authors:  Li-Dong Wang; Qi Zhou; Jun-Ping Wei; Wan-Cai Yang; Xin Zhao; Li-Xia Wang; Jian-Xiang Zou; Shan-Shan Gao; Yong-Xin Li; CS Yang
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

7.  Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2.

Authors:  Hiroshi Nishihara; Shinae Kizaka-Kondoh; Paul A Insel; Lars Eckmann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-01       Impact factor: 11.205

8.  The mitochondrial protein hTID-1 partners with the caspase-cleaved adenomatous polyposis cell tumor suppressor to facilitate apoptosis.

Authors:  Jiang Qian; Erin M Perchiniak; Kristine Sun; Joanna Groden
Journal:  Gastroenterology       Date:  2009-11-06       Impact factor: 22.682

9.  Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes.

Authors:  Yang-Yi Fan; Thomas E Spencer; Naisyin Wang; Mary P Moyer; Robert S Chapkin
Journal:  Carcinogenesis       Date:  2003-07-04       Impact factor: 4.944

10.  False-positive TUNEL staining observed in SV40 based transgenic murine prostate cancer models.

Authors:  M D Lawrence; B J Blyth; R J Ormsby; W D Tilley; P J Sykes
Journal:  Transgenic Res       Date:  2013-02-20       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.